Related Experiment Video

Updated: Aug 8, 2026

Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

Topoisomerase I interactive agents

Mark N Kirstein1, P Kellie Turner, Clinton F Stewart

  • 1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.

Cancer Chemotherapy and Biological Response Modifiers
|April 22, 2003
PubMed

Insights

Understanding topoisomerase I interactions is key for developing better cancer drugs. Further research on drug mechanisms and optimal dosing schedules will improve patient outcomes and guide future therapeutic strategies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Topoisomerase I (TOP1) interactive agents, initially camptothecin derivatives, are crucial in cancer therapy.
  • Rational drug design requires understanding the precise mechanism of TOP1 interaction and its effect on cell death.

Purpose of the Study:

  • To explore the significance of TOP1 crystal structure elucidation for developing novel TOP1 interactive agents.
  • To emphasize the need for preclinical studies to determine mechanisms of action and optimize dosing strategies for existing and future TOP1 inhibitors.
  • To guide future clinical trials in designing effective combination regimens and optimizing administration schedules for improved therapeutic indices.

Main Methods:

  • Elucidation of topoisomerase I crystal structure.
  • Preclinical studies investigating mechanisms of cell death induced by TOP1 inhibitors.
  • Analysis of pharmacokinetic and pharmacodynamic data to determine optimal dosing schedules.
  • Investigation of mechanisms underlying dose-limiting toxicities of current TOP1 inhibitors.

Main Results:

  • Knowledge of TOP1 structure facilitates rational design of improved interactive agents.
  • Preclinical data suggest protracted dosing for S-phase-specific agents like irinotecan and topotecan.
  • Understanding toxicity mechanisms, such as irinotecan glucuronidation, can inform maximal dosing strategies.

Conclusions:

  • Optimizing the use of current topoisomerase I inhibitors through rigorous preclinical and clinical studies is paramount.
  • Future drug development should leverage structural and mechanistic insights for rational design and improved therapeutic outcomes.
  • Continued research into TOP1 inhibitor mechanisms and toxicities is essential for maximizing their clinical benefit.

More Related Videos

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples10:13

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples

Published on: December 2, 2022

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Related Concept Videos

DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...